NEW

Philips Partners with DiA Imaging Analysis

Royal Philips and DiA Imaging Analysis Ltd., a provider of AI-powered applications for ultrasound, have announced a strategic partnership* to deliver automated solutions to clinicians at the point-of-care.

Philips spotlights new solutions at ECR 2021

Royal Philips has announced its participation in the European Congress of Radiology (ECR) virtual event, March 3-7, 2021, where the company will feature new and enhanced diagnostic and interventional solutions that further expand its Radiology Workflow Suite, connecting data, technology and people across the imaging enterprise.

Epsilon Imaging Partners with Siemens Healthineers

Epsilon Imaging, a visualization and analysis software provider transforming cardiac diagnostic workflow with strain imaging, has announced a partnership with Siemens Healthineers, a leading developer of medical imaging and information management solutions, to offer syngo Dynamics users EchoInsight visualization and analysis with strain imaging.

iRad Announces a Distributorship Agreement with FUJIFILM Medical Systems

iRad, Innovative Radiology Equipment Sales and Services, LLC has announced a distributorship agreement with FUJIFILM Medical Services.

Ascendum Acquires EndoWays LTD

On February 8, EndoWays, a developer of a disposable robotic system for the cath lab, announced the completion of an acquisition of a majority of its shares by Ascendum at an undisclosed cash amount.

EndoWays is a portfolio company of MEDX Xelerator. During its incubation time, EndoWays developed a first-of-its-kind, fully disposable robotic system to support navigation and operation within blood vessels in neurovascular, peripheral and cardiac procedures. The deal will provide EndoWays with access to the vast experience and network of the Ascendum team, helping accelerate its clinical and commercial development, especially in China.

“Our vision is to provide an easy- to-use and cost-effective tool for the cath lab that will facilitate difficult procedures and allow physicians to work accurately through tortuous blood vessels away from radiation,” said Noam Shamay, EndoWays’ founder and CEO. “With the support of Ascendum’s experience and resources we can continue to make this vision a reality.”

Shamay will serve as the company‘s chief technology officer post acquisition.

“EndoWays was our very first incubator portfolio company, making its acquisition after less than three years since its founding, a significant milestone,” said Shai Policker, CEO of MEDX Xelerator. “We are proud of the achievements of the team and look forward to the company’s continued success.”

“EndoWays provides attractive competitive advantages that can accelerate entry of robotics into the cath lab, which we believe will be highly valuable to future clinical practice,” explained Serena Shao, founder and managing partner from Ascendum. “After the closing, Endoways is going to move into the incubator of our strategic partner, DiNovA Medtech, based in Israel, to continue development until commercial launch.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *